The prescription volume has grown from roughly 3,000 per 100,000 commercial members in 2018 to 22,000 per 100,000 members in 2023, which the commission said is a more than seven-fold increase
Similarly, a 2023 study published in the Journal of the American Medical Association (JAMA) found that individuals taking GLP-1 drugs were more than four times as likely to experience bowel obstruction compared with patients using bupropion-naltrexone, another class of weight-management medication
7) Zinc Plays a role in wound healing and skin repair
But growth hormone pathways are not cosmetic shortcuts
Hamazaki, J., & Murata, S
Once-weekly dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes